Overnight switch from levetiracetam to brivaracetam. Safety and tolerability

Brivaracetam is a newer antiseizure medication than levetiracetam. It has a more selective action on the synaptic vesicle glycoprotein 2A binding site, and it seems to provide a more favorable neuropsychiatric profile. The aim of this study was to assess the safety and tolerability of an overnight s...

Descripción completa

Detalles Bibliográficos
Autores principales: Abraira, L., Salas-Puig, J., Quintana, M., Seijo-Raposo, I.M., Santamarina, E., Fonseca, E., Toledo, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640256/
https://www.ncbi.nlm.nih.gov/pubmed/34901817
http://dx.doi.org/10.1016/j.ebr.2021.100504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640256/
https://www.ncbi.nlm.nih.gov/pubmed/34901817
http://dx.doi.org/10.1016/j.ebr.2021.100504

Ejemplares similares